🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMASH prevalence in GLP-1 users — what worked for you? Page 3

MASH prevalence in GLP-1 users — what worked for you?

claudia_zurich Mon, Dec 8, 2025 at 7:23 PM 12 replies 1,032 viewsPage 3 of 3
RetaRick_CA
VIP Member
2,012
9,876
Jan 2024
California
Dec 11, 2025 at 12:09 AM#11
VendorMark said:
Start from the measurement rather than the conclusion.

That is right for the common case. Whether it is right for the case being asked about depends on a detail that has not been given.

That is the short version; the long version is somebody else's post.

Last edited: Dec 11, 2025 at 1:09 AM
41 14SkepticalSean, Dr.CardioMD, EndoResFellow and 38 others
Reply Quote Save Share Report
JenMemphis
Member
267
1,234
Jan 2025
Memphis, TN
Dec 12, 2025 at 12:46 AM#12
Dr.GutHealth said:
Liver ultrasound comparison for liver and MASH: my hepatologist ordered serial ultrasounds to track NAFLD regression.

This is exactly what I could not find anywhere else. Adding it to my notes with a link back to this thread.

42 15BenResearch_OR, MikeKY_noInsulin, Dr.RaviCardio and 39 others
Reply Quote Save Share Report
MaxMetOK
Member
312
1,123
Dec 2024
Oklahoma
Dec 13, 2025 at 1:22 AM#13
VendorMark said:
Start from the measurement rather than the conclusion.

Pushing back on VendorMark here. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.

43 16DoseLogDan, SleepFixSam, PurityPaulOR and 40 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
josh_phd_bmore
Member
389
1,678
Jul 2024
Baltimore, MD
Dec 14, 2025 at 1:58 AM#14

Adding the numbers, since they settle part of this. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

44 17KarenAZ_mom, zoe_NC, Dr.ObesityLA and 41 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Dec 15, 2025 at 2:33 AM#15

Moderator note: a couple of off-topic posts removed. Thread quality here is what the rules are for. Keep it up.

45 18PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 42 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register